Overview Factor VIIa in Acute Intracerebral Haemorrhage Status: Completed Trial end date: 2007-04-01 Target enrollment: Participant gender: Summary This trial is conducted in Japan. The purpose of this trial is to evaluate the safety and preliminary efficacy of Activated Recombinant Factor VII (NN-007) in patients with acute intracerebral haemorrhage. Phase: Phase 2 Details Lead Sponsor: Novo Nordisk A/S